Zobrazeno 1 - 10
of 220
pro vyhledávání: '"Hideyuki Ikematsu"'
Autor:
Naoki Tani, Hideyuki Ikematsu, Haruka Watanabe, Takeyuki Goto, Yuki Yanagihara, Yasuo Kurata, Yukiko Harada, Takahiko Horiuchi, Koichi Akashi, Nobuyuki Shimono, Yong Chong
Publikováno v:
Vaccine: X, Vol 18, Iss , Pp 100489- (2024)
Background: SARS-CoV-2 mRNA vaccination, recognized for high immunogenicity, frequently induces adverse reactions, especially fever. We previously reported a correlation between post-vaccination fever and specific antibody responses to the primary se
Externí odkaz:
https://doaj.org/article/3d728d7a2e014dbeab7cb1dc7ff99612
Autor:
Yong Chong, Takeyuki Goto, Haruka Watanabe, Naoki Tani, Akiko Yonekawa, Hideyuki Ikematsu, Nobuyuki Shimono, Yosuke Tanaka, Koichi Akashi
Publikováno v:
Immunity, Inflammation and Disease, Vol 11, Iss 8, Pp n/a-n/a (2023)
Abstract Background Infection control during COVID‐19 outbreaks in nursing facilities is a critical public health issue. Antibody responses before and after the fourth (second booster) dose of wild‐type severe acute respiratory syndrome coronavir
Externí odkaz:
https://doaj.org/article/256c29d7acc74bd1b714cbb0a6449909
Autor:
Naoki Tani, Hideyuki Ikematsu, Takeyuki Goto, Kei Gondo, Yuki Yanagihara, Yasuo Kurata, Ryo Oishi, Junya Minami, Kyoko Onozawa, Sukehisa Nagano, Hiroyuki Kuwano, Koichi Akashi, Nobuyuki Shimono, Yong Chong
Publikováno v:
Vaccine: X, Vol 12, Iss , Pp 100224- (2022)
The relation between pre-vaccination antipyretic use and antibody responses to SARS-CoV-2 vaccination has been unclear. We measured the pre- and post-BNT162b2 booster spike-specific IgG titers and recorded antipyretic use and adverse reactions for SA
Externí odkaz:
https://doaj.org/article/7d5f1578696f47d39ca69946bf76a72f
Autor:
Yong Chong, Naoki Tani, Hideyuki Ikematsu, Nobuto Terazawa, Hitoshi Nakashima, Nobuyuki Shimono, Koichi Akashi, Yosuke Tanaka
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background The Pandemic of coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has critically impacted the spread of infection within nursing facilities. We evaluated the usefulness of gene
Externí odkaz:
https://doaj.org/article/50db76d6cf694d6c9cae1b1a91972617
Autor:
Takeyuki Goto, Naoki Tani, Hideyuki Ikematsu, Kei Gondo, Ryo Oishi, Junya Minami, Kyoko Onozawa, Hiroyuki Kuwano, Koichi Akashi, Nobuyuki Shimono, Yong Chong
Publikováno v:
PLoS ONE, Vol 17, Iss 7 (2022)
Waning humoral immunity after mRNA vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a significant problem for public health. Breakthrough infection in hospitals over several months after vaccination has not been ful
Externí odkaz:
https://doaj.org/article/27f8dc62ebce4e469b756b930490659b
Autor:
Lidia Oostvogels, Thomas C. Heineman, Robert W. Johnson, Myron J. Levin, Janet E. McElhaney, Peter Van den Steen, Toufik Zahaf, Alemnew F. Dagnew, Roman Chlibek, Javier Diez-Domingo, Iris S. Gorfinkel, Caroline Hervé, Shinn-Jang Hwang, Hideyuki Ikematsu, George Kalema, Himal Lal, Shelly A. McNeil, Tomas Mrkvan, Karlis Pauksens, Jan Smetana, Daisuke Watanabe, Lily Yin Weckx, Anthony L. Cunningham
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 12, Pp 2865-2872 (2019)
In two pivotal efficacy studies (ZOE-50; ZOE-70), the adjuvanted recombinant zoster vaccine (RZV) demonstrated >90% efficacy against herpes zoster (HZ). Adults aged ≥50 or ≥70 years (ZOE-50 [NCT01165177]; ZOE-70 [NCT01165229]) were randomized to
Externí odkaz:
https://doaj.org/article/2de77cc0739443df82239135c7c026b5
Autor:
Yong Chong, Hideyuki Ikematsu
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 3, Pp 518-522 (2018)
Influenza A/H3N2 viruses are the most common and virulent subtypes for humans. Antigenic drift, changes in antigenicity through the accumulation of mutations in the hemagglutinin (HA) gene is chiefly responsible for the continuing circulation of A/H3
Externí odkaz:
https://doaj.org/article/51037f8e56c9452285f18ea84911f3cf
Autor:
Nao Jounai, Megumi Yoshioka, Miyuki Tozuka, Kazue Inoue, Tatsuya Oka, Kazuki Miyaji, Katsuyasu Ishida, Naoki Kawai, Hideyuki Ikematsu, Chiaki Kawakami, Hiroyuki Shimizu, Masaaki Mori, Ken J. Ishii, Fumihiko Takeshita
Publikováno v:
EBioMedicine, Vol 16, Iss C, Pp 124-135 (2017)
Respiratory syncytial virus (RSV) is one of the most prevalent causative agents of lower respiratory tract infections worldwide, especially in infants around 3 to 4 months old. Infants at such a young age have maternally-transferred passive antibodie
Externí odkaz:
https://doaj.org/article/b40c38bc15cb4dbab430c322580a0d67
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 8, Iss 8, Pp 1119-1125 (2012)
Objective: This study assessed the immunogenicity, long-term persistence of immune response and safety of a single dose of an A/California/07/2009 H1N1 pandemic influenza vaccine adjuvanted with AS03 (α-tocopherol and squalene based oil-in-water emu
Externí odkaz:
https://doaj.org/article/91a68d0a97004443845f55b6397f7d4f
Autor:
Naoki Tani, Naoki Kawai, Hideyuki Ikematsu, Takuma Bando, Norio Iwaki, Yoshio Takasaki, Shizuo Shindo, Yong Chong, Seizaburo Kashiwagi
Publikováno v:
Journal of Infection and Chemotherapy. 28:890-895
Large scale investigation of the clinical effectiveness of neuraminidase inhibitors for circulating influenza viruses are important along with the surveillance of virus susceptibility in vitro.The duration of fever and other influenza symptoms as mar